- Home
- CADL vs SIGIP Comparison
CADL vs SIGIP Comparison
Compare CADL & SIGIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CADL | SIGIP |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | United States |
| Employees | N/A | 2800 |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 280.3M | N/A |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CADL | SIGIP |
|---|---|---|
| Price | $4.92 | $16.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $19.71 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 4.2K |
| Earning Date | 03-12-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.62 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $125,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.25 | $16.35 |
| 52 Week High | $8.69 | $18.71 |
Technical Indicators
Market Signals| Indicator | CADL | SIGIP |
|---|---|---|
| Relative Strength Index (RSI) | 43.79 | 24.86 |
| Support Level | $4.57 | N/A |
| Resistance Level | $5.42 | $17.07 |
| Average True Range (ATR) | 0.25 | 0.14 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 44.44 | 0.00 |
Price Performance
Historical ComparisonAbout CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About SIGIP Selective Insurance Group Inc. Depositary Shares each representing a 1/1000th interest in a share of 4.60% Non-Cumulative Preferred Stock Series B
Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, and Investments. Majority of revenue is gained from Standard Commercial Lines segment, which comprises of property and casualty insurance products and services provided in the standard marketplace to commercial enterprises, which are typically businesses, non-profit organizations, and local government agencies.